Merkel Cell Carcinoma

Hematology/Oncology Clinics of North America

Volumn 26, Issue 6, 2012, Pages 1351-1374

  Han, Sandra Y ^a   North, Jeffrey P ^a   Canavan, Theresa ^a   Kim, Nancy ^b   Yu, Siegrid S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Spectrum Dermatology   (United States)

Author keywords

Merkel cell; Neuroendocrine carcinoma; Skin cancer

Indexed keywords

HUMAN; MERKEL CELL TUMOR; REVIEW; SKIN TUMOR;

CARCINOMA, MERKEL CELL; HUMANS; SKIN NEOPLASMS;

EID: 84868246768     PISSN: 08898588     EISSN: 15581977     Source Type: Journal    
DOI: 10.1016/j.hoc.2012.08.007     Document Type: Review

References (137)

1. Toker C. Trabecular carcinoma of the skin. Arch Dermatol 1972, 105(1):107-110.
2. Tang C.K., Toker C. Trabecular carcinoma of the skin: an ultrastructural study. Cancer 1978, 42(5):2311-2321.
3. Boulais N., Misery L. Merkel cells. J Am Acad Dermatol 2007, 57(1):147-165.
4. Lemos B.D., Storer B.E., Iyer J.G., et al. Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system. J Am Acad Dermatol 2010, 63(5):751-761.
5. Albores-Saavedra J., Batich K., Chable-Montero F., et al. Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: a population based study. J Cutan Pathol 2010, 37(1):20-27.
6. Agelli M., Clegg L.X. Epidemiology of primary Merkel cell carcinoma in the United States. J Am Acad Dermatol 2003, 49(5):832-841.
7. Agelli M., Clegg L.X., Becker J.C., et al. The etiology and epidemiology of Merkel cell carcinoma. Curr Probl Cancer 2010, 34(1):14-37.
8. Hodgson N.C. Merkel cell carcinoma: changing incidence trends. J Surg Oncol 2005, 89(1):1-4.
9. Reichgelt B.A., Visser O. Epidemiology and survival of Merkel cell carcinoma in the Netherlands. A population-based study of 808 cases in 1993-2007. Eur J Cancer 2011, 47(4):579-585.
10. Kaae J., Hansen A.V., Biggar R.J., et al. Merkel cell carcinoma: incidence, mortality, and risk of other cancers. J Natl Cancer Inst 2010, 102(11):793-801.
11. Girschik J., Thorn K., Beer T.W., et al. Merkel cell carcinoma in Western Australia: a population-based study of incidence and survival. Br J Dermatol 2011, 165(5):1051-1057.
12. Lunder E.J., Stern R.S. Merkel-cell carcinomas in patients treated with methoxsalen and ultraviolet A radiation. N Engl J Med 1998, 339(17):1247-1248.
13. Feng H., Shuda M., Chang Y., et al. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008, 319(5866):1096-1100.
14. Kuwamoto S. Recent advances in the biology of Merkel cell carcinoma. Hum Pathol 2011, 42(8):1063-1077.
15. Gardner S.D., Field A.M., Coleman D.V., et al. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet 1971, 1(7712):1253-1257.
16. Padgett B.L., Walker D.L., ZuRhein G.M., et al. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1971, 1(7712):1257-1260.
17. Poulin D.L., DeCaprio J.A. Is there a role for SV40 in human cancer?. J Clin Oncol 2006, 24(26):4356-4365.
18. Shuda M., Feng H., Kwun H.J., et al. T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus. Proc Natl Acad Sci U S A 2008, 105(42):16272-16277.
19. Viscidi R.P., Rollison D.E., Sondak V.K., et al. Age-specific seroprevalence of Merkel cell polyomavirus, BK virus, and JC virus. Clin Vaccine Immunol 2011, 18(10):1737-1743.
20. Kean J.M., Rao S., Wang M., et al. Seroepidemiology of human polyomaviruses. PLoS Pathog 2009, 5(3):e1000363.
21. Tolstov Y.L., Pastrana D.V., Feng H., et al. Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays. Int J Cancer 2009, 125(6):1250-1256.
22. Carter J.J., Paulson K.G., Wipf G.C., et al. Association of Merkel cell polyomavirus-specific antibodies with Merkel cell carcinoma. J Natl Cancer Inst 2009, 101(21):1510-1522.
23. Chen T., Hedman L., Mattila P.S., et al. Serological evidence of Merkel cell polyomavirus primary infections in childhood. J Clin Virol 2011, 50(2):125-129.
24. Touze A., Le Bidre E., Laude H., et al. High levels of antibodies against merkel cell polyomavirus identify a subset of patients with merkel cell carcinoma with better clinical outcome. J Clin Oncol 2011, 29(12):1612-1619.
25. Pastrana D.V., Tolstov Y.L., Becker J.C., et al. Quantitation of human seroresponsiveness to Merkel cell polyomavirus. PLoS Pathog 2009, 5(9):e1000578.
26. Paulson K.G., Carter J.J., Johnson L.G., et al. Antibodies to merkel cell polyomavirus T antigen oncoproteins reflect tumor burden in merkel cell carcinoma patients. Cancer Res 2010, 70(21):8388-8397.
27. Houben R., Shuda M., Weinkam R., et al. Merkel cell polyomavirus-infected Merkel cell carcinoma cells require expression of viral T antigens. J Virol 2010, 84(14):7064-7072.
28. Paulson K.G., Iyer J.G., Tegeder A.R., et al. Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival. J Clin Oncol 2011, 29(12):1539-1546.
29. Sihto H., Bohling T., Kavola H., et al. Tumor Infiltrating immune cells and outcome of merkel cell carcinoma: a population-based study. Clin Cancer Res 2012, 18(10):2872-2881.
30. Buell J.F., Trofe J., Hanaway M.J., et al. Immunosuppression and Merkel cell cancer. Transplant Proc 2002, 34(5):1780-1781.
31. Engels E.A., Frisch M., Goedert J.J., et al. Merkel cell carcinoma and HIV infection. Lancet 2002, 359(9305):497-498.
32. Penn I., First M.R. Merkel's cell carcinoma in organ recipients: report of 41 cases. Transplantation 1999, 68(11):1717-1721.
33. Gooptu C., Woollons A., Ross J., et al. Merkel cell carcinoma arising after therapeutic immunosuppression. Br J Dermatol 1997, 137(4):637-641.
34. Lentz S.R., Krewson L., Zutter M.M. Recurrent neuroendocrine (Merkel cell) carcinoma of the skin presenting as marrow failure in a man with systemic lupus erythematosus. Med Pediatr Oncol 1993, 21(2):137-141.
35. Nemoto I., Sato-Matsumura K.C., Fujita Y., et al. Leukaemic dissemination of Merkel cell carcinoma in a patient with systemic lupus erythematosus. Clin Exp Dermatol 2008, 33(3):270-272.
36. McLoone N.M., McKenna K., Edgar D., et al. Merkel cell carcinoma in a patient with chronic sarcoidosis. Clin Exp Dermatol 2005, 30(5):580-582.
37. Lillis J., Ceilley R.I., Nelson P. Merkel cell carcinoma in a patient with autoimmune hepatitis. J Drugs Dermatol 2005, 4(3):357-359.
38. Satolli F., Venturi C., Vescovi V., et al. Merkel-cell carcinoma in Behcet's disease. Acta Derm Venereol 2005, 85(1):79.
39. Gianfreda M., Caiffi S., De Franceschi T., et al. Minerva Med 2002, 93(3):219-222. [in Italian].
40. Heath M., Jaimes N., Lemos B., et al. Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. J Am Acad Dermatol 2008, 58(3):375-381.
41. Koljonen V., Kukko H., Pukkala E., et al. Chronic lymphocytic leukaemia patients have a high risk of Merkel-cell polyomavirus DNA-positive Merkel-cell carcinoma. Br J Cancer 2009, 101(8):1444-1447.
42. Tadmor T., Liphshitz I., Aviv A., et al. Increased incidence of chronic lymphocytic leukaemia and lymphomas in patients with Merkel cell carcinoma-a population based study of 335 cases with neuroendocrine skin tumour. Br J Haematol 2012, 157(4):457-462.
43. Miller R.W., Rabkin C.S. Merkel cell carcinoma and melanoma: etiological similarities and differences. Cancer Epidemiol Biomarkers Prev 1999, 8(2):153-158.
44. Friedlaender M.M., Rubinger D., Rosenbaum E., et al. Temporary regression of Merkel cell carcinoma metastases after cessation of cyclosporine. Transplantation 2002, 73(11):1849-1850.
45. Muirhead R., Ritchie D.M. Partial regression of Merkel cell carcinoma in response to withdrawal of azathioprine in an immunosuppression-induced case of metastatic Merkel cell carcinoma. Clin Oncol 2007, 19(1):96.
46. Gess A.J., Silkiss R.Z. A merkel cell carcinoma of the lacrimal gland. Ophthal Plast Reconstr Surg 2012, 28(1):e11-e13.
47. Ghaderi M., Coury J., Oxenberg J., et al. Primary Merkel cell carcinoma of the parotid gland. Dermatol Surg 2010, 89(7):E24-E27.
48. Iavazzo C., Terzi M., Arapantoni-Dadioti P., et al. Vulvar merkel carcinoma: a case report. Case Report Med 2011, 2011:546972.
49. Tomic S., Warner T.F., Messing E., et al. Penile Merkel cell carcinoma. Urology 1995, 45(6):1062-1065.
50. Sarma D.P., Heagley D.E., Chalupa J., et al. An unusual clinical presentation of merkel cell carcinoma: a case report. Case Report Med 2010, 2010:905414.
51. Huang G.S., Chang W.C., Lee H.S., et al. Merkel cell carcinoma arising from the subcutaneous fat of the arm with intact skin. Dermatol Surg 2005, 31(6):717-719.
52. Balaton A.J., Capron F., Baviera E.E., et al. Neuroendocrine carcinoma (Merkel cell tumor?) presenting as a subcutaneous tumor. An ultrastructural and immunohistochemical study of three cases. Pathol Res Pract 1989, 184(2):211-216.
53. Tsai Y.Y., Hsiao C.H., Chiu H.C., et al. CK7+/CK20- Merkel cell carcinoma presenting as inguinal subcutaneous nodules with subsequent epidermotropic metastasis. Acta Derm Venereol 2010, 90(4):438-439.
54. Gambichler T., Kobus S., Kreuter A., et al. Primary merkel cell carcinoma clinically presenting as deep oedematous mass of the groin. Eur J Med Res 2010, 15(6):274-276.
55. Eusebi V., Capella C., Cossu A., et al. Neuroendocrine carcinoma within lymph nodes in the absence of a primary tumor, with special reference to Merkel cell carcinoma. Am J Surg Pathol 1992, 16(7):658-666.
56. Straka J.A., Straka M.B. A review of Merkel cell carcinoma with emphasis on lymph node disease in the absence of a primary site. Am J Otol 1997, 18(1):55-65.
57. Ferrara G., Ianniello G.P., Di Vizio D., et al. Lymph node Merkel cell carcinoma with no evidence of cutaneous tumor-report of two cases. Tumori 1997, 83(5):868-872.
58. Samarendra P., Berkowitz L., Kumari S., et al. Primary nodal neuroendocrine (Merkel cell) tumor in a patient with HIV infection. South Med J 2000, 93(9):920-922.
59. Fotia G., Barni R., Bellan C., et al. Lymph nodal Merkel cell carcinoma: primary or metastatic disease? a clinical case. Tumori 2002, 88(5):424-426.
60. Silberstein E., Koretz M., Cagnano E., et al. Neuroendocrine (Merkel cell) carcinoma in regional lymph nodes without primary site. Isr Med Assoc J 2003, 5(6):450-451.
61. Kuwabara H., Mori H., Uda H., et al. Nodal neuroendocrine (Merkel cell) carcinoma without an identifiable primary tumor. Acta Cytol 2003, 47(3):515-517.
62. Nazarian Y., Shalmon B., Horowitz Z., et al. Merkel cell carcinoma of unknown primary site. J Laryngol Otol 2007, 121(4):e1.
63. Boghossian V., Owen I.D., Nuli B., et al. Neuroendocrine (Merkel cell) carcinoma of the retroperitoneum with no identifiable primary site. World J Surg Oncol 2007, 5:117.
64. Kim E.J., Kim H.S., Kim H.O., et al. Merkel cell carcinoma of the inguinal lymph node with an unknown primary site. J Dermatol 2009, 36(3):170-173.
65. De Cicco L., Vavassori A., Jereczek-Fossa B.A., et al. Lymph node metastases of Merkel cell carcinoma from unknown primary site: report of three cases. Tumori 2008, 94(5):758-761.
66. Kuwamoto S., Higaki H., Kanai K., et al. Association of Merkel cell polyomavirus infection with morphologic differences in Merkel cell carcinoma. Hum Pathol 2011, 42(5):632-640.
67. Andea A.A., Coit D.G., Amin B., et al. Merkel cell carcinoma: histologic features and prognosis. Cancer 2008, 113(9):2549-2558.
68. Skelton H.G., Smith K.J., Hitchcock C.L., et al. Merkel cell carcinoma: analysis of clinical, histologic, and immunohistologic features of 132 cases with relation to survival. J Am Acad Dermatol 1997, 37(5 Pt 1):734-739.
69. Fields R.C., Busam K.J., Chou J.F., et al. Five hundred patients with Merkel cell carcinoma evaluated at a single institution. Ann Surg 2011, 254(3):465-473. [discussion: 473-5].
70. Kukko H.M., Koljonen V.S., Tukiainen E.J., et al. Vascular invasion is an early event in pathogenesis of Merkel cell carcinoma. Mod Pathol 2010, 23(8):1151-1156.
71. Asioli S., Righi A., Volante M., et al. p63 expression as a new prognostic marker in Merkel cell carcinoma. Cancer 2007, 110(3):640-647.
72. Allen P.J., Bowne W.B., Jaques D.P., et al. Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol 2005, 23(10):2300-2309.
73. Allen P.J., Zhang Z.F., Coit D.G. Surgical management of Merkel cell carcinoma. Ann Surg 1999, 229(1):97-105.
74. Yiengpruksawan A., Coit D.G., Thaler H.T., et al. Merkel cell carcinoma. Prognosis and management. Arch Surg 1991, 126(12):1514-1519.
75. Clark J.R., Veness M.J., Gilbert R., et al. Merkel cell carcinoma of the head and neck: is adjuvant radiotherapy necessary?. Head Neck 2007, 29(3):249-257.
76. Smith V.A., Madan O.P., Lentsch E.J. Tumor location is an independent prognostic factor in head and neck Merkel cell carcinoma. Otolaryngol Head Neck Surg 2012, 146(3):403-408.
77. Ott M.J., Tanabe K.K., Gadd M.A., et al. Multimodality management of Merkel cell carcinoma. Arch Surg 1999, 134(4):388-392. [discussion: 392-3].
78. Eftekhari F., Wallace S., Silva E.G., et al. Merkel cell carcinoma of the skin: imaging and clinical features in 93 cases. Br J Radiol 1996, 69(819):226-233.
79. Gollub M.J., Gruen D.R., Dershaw D.D. Merkel cell carcinoma: CT findings in 12 patients. AJR Am J Roentgenol 1996, 167(3):617-620.
80. Nguyen B.D., McCullough A.E. Imaging of Merkel cell carcinoma. Radiographics 2002, 22(2):367-376.
81. Anderson S.E., Beer K.T., Banic A., et al. MRI of merkel cell carcinoma: histologic correlation and review of the literature. AJR Am J Roentgenol 2005, 185(6):1441-1448.
82. Yao M., Smith R.B., Hoffman H.T., et al. Merkel cell carcinoma: two case reports focusing on the role of fluorodeoxyglucose positron emission tomography imaging in staging and surveillance. Am J Clin Oncol 2005, 28(2):205-210.
83. Lin O., Thomas A., Singh A., et al. Complementary role of positron emission tomography in merkel cell carcinoma. South Med J 2004, 97(11):1110-1112.
84. Concannon R., Larcos G.S., Veness M. The impact of (18)F-FDG PET-CT scanning for staging and management of Merkel cell carcinoma: results from Westmead Hospital, Sydney, Australia. J Am Acad Dermatol 2010, 62(1):76-84.
85. Shintani S.A., Foote R.L., Lowe V.J., et al. Utility of PET/CT imaging performed early after surgical resection in the adjuvant treatment planning for head and neck cancer. Int J Radiat Oncol Biol Phys 2008, 70(2):322-329.
86. Peloschek P., Novotny C., Mueller-Mang C., et al. Diagnostic imaging in Merkel cell carcinoma: lessons to learn from 16 cases with correlation of sonography, CT, MRI and PET. Eur J Radiol 2010, 73(2):317-323.
87. Maury G., Dereure O., Du-Thanh A., et al. Interest of (18)F-FDG PET-CT scanning for staging and management of merkel cell carcinoma: a retrospective study of 15 patients. J Eur Acad Dermatol Venereol 2011, 25(12):1420-1427.
88. Werner M.K., Aschoff P., Reimold M., et al. FDG-PET/CT-guided biopsy of bone metastases sets a new course in patient management after extensive imaging and multiple futile biopsies. Br J Radiol 2011, 84(999):e65-e67.
89. National Comprehensive Cancer Network. NCCN Clinical Practice Guidlines in Oncology-Merkel cell carcinoma. 2012(Version 1.2012).
90. O'Connor W.J., Roenigk R.K., Brodland D.G. Merkel cell carcinoma. Comparison of Mohs micrographic surgery and wide excision in eighty-six patients. Dermatol Surg 1997, 23(10):929-933.
91. Boyer J.D., Zitelli J.A., Brodland D.G., et al. Local control of primary Merkel cell carcinoma: review of 45 cases treated with Mohs micrographic surgery with and without adjuvant radiation. J Am Acad Dermatol 2002, 47(6):885-892.
92. Hitchcock C.L., Bland K.I., Laney R.G., et al. Neuroendocrine (Merkel cell) carcinoma of the skin. Its natural history, diagnosis, and treatment. Ann Surg 1988, 207(2):201-207.
93. Messina J.L., Reintgen D.S., Cruse C.W., et al. Selective lymphadenectomy in patients with Merkel cell (cutaneous neuroendocrine) carcinoma. Ann Surg Oncol 1997, 4(5):389-395.
94. Gupta S.G., Wang L.C., Penas P.F., et al. Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: the Dana-Farber experience and meta-analysis of the literature. Arch Dermatol 2006, 142(6):685-690.
95. Fields R.C., Busam K.J., Chou J.F., et al. Recurrence and survival in patients undergoing sentinel lymph node biopsy for merkel cell carcinoma: analysis of 153 patients from a single institution. Ann Surg Oncol 2011, 18(9):2529-2537.
96. Mehrany K., Otley C.C., Weenig R.H., et al. A meta-analysis of the prognostic significance of sentinel lymph node status in Merkel cell carcinoma. Dermatol Surg 2002, 28(2):113-117. [discussion: 117].
97. Stokes J.B., Graw K.S., Dengel L.T., et al. Patients with Merkel cell carcinoma tumors < or = 1.0 cm in diameter are unlikely to harbor regional lymph node metastasis. J Clin Oncol 2009, 27(23):3772-3777.
98. Sarnaik A.A., Zager J.S., Cox L.E., et al. Routine omission of sentinel lymph node biopsy for merkel cell carcinoma <= 1 cm is not justified. J Clin Oncol 2010, 28(1):e7.
99. Schwartz J.L., Griffith K.A., Lowe L., et al. Features predicting sentinel lymph node positivity in Merkel cell carcinoma. J Clin Oncol 2011, 29(8):1036-1041.
100. Tai P., Yu E., Assouline A., et al. Management of Merkel cell carcinoma with emphasis on small primary tumors-a case series and review of the current literature. J Drugs Dermatol 2010, 9(2):105-110.
101. Jabbour J., Cumming R., Scolyer R.A., et al. Merkel cell carcinoma: assessing the effect of wide local excision, lymph node dissection, and radiotherapy on recurrence and survival in early-stage disease-results from a review of 82 consecutive cases diagnosed between 1992 and 2004. Ann Surg Oncol 2007, 14(6):1943-1952.
102. Su L.D., Lowe L., Bradford C.R., et al. Immunostaining for cytokeratin 20 improves detection of micrometastatic Merkel cell carcinoma in sentinel lymph nodes. J Am Acad Dermatol 2002, 46(5):661-666.
103. Pape E., Rezvoy N., Penel N., et al. Radiotherapy alone for Merkel cell carcinoma: a comparative and retrospective study of 25 patients. J Am Acad Dermatol 2011, 65(5):983-990.
104. Koh C.S., Veness M.J. Role of definitive radiotherapy in treating patients with inoperable Merkel cell carcinoma: the Westmead Hospital experience and a review of the literature. Australas J Dermatol 2009, 50(4):249-256.
105. Veness M., Foote M., Gebski V., et al. The role of radiotherapy alone in patients with merkel cell carcinoma: reporting the Australian experience of 43 patients. Int J Radiat Oncol Biol Phys 2010, 78(3):703-709.
106. Fang L.C., Lemos B., Douglas J., et al. Radiation monotherapy as regional treatment for lymph node-positive Merkel cell carcinoma. Cancer 2010, 116(7):1783-1790.
107. Lewis K.G., Weinstock M.A., Weaver A.L., et al. Adjuvant local irradiation for Merkel cell carcinoma. Arch Dermatol 2006, 142(6):693-700.
108. Gillenwater A.M., Hessel A.C., Morrison W.H., et al. Merkel cell carcinoma of the head and neck: effect of surgical excision and radiation on recurrence and survival. Arch Otolaryngol Head Neck Surg 2001, 127(2):149-154.
109. Mojica P., Smith D., Ellenhorn J.D. Adjuvant radiation therapy is associated with improved survival in Merkel cell carcinoma of the skin. J Clin Oncol 2007, 25(9):1043-1047.
110. Fields R.C., Busam K.J., Chou J.F., et al. Recurrence after complete resection and selective use of adjuvant therapy for stage I through III Merkel cell carcinoma. Cancer 2012, 118(13):3311-3320.
111. Poulsen M.G., Rischin D., Porter I., et al. Does chemotherapy improve survival in high-risk stage I and II Merkel cell carcinoma of the skin?. Int J Radiat Oncol Biol Phys 2006, 64(1):114-119.
112. Kokoska E.R., Kokoska M.S., Collins B.T., et al. Early aggressive treatment for Merkel cell carcinoma improves outcome. Am J Surg 1997, 174(6):688-693.
113. Garneski K.M., Nghiem P. Merkel cell carcinoma adjuvant therapy: current data support radiation but not chemotherapy. J Am Acad Dermatol 2007, 57(1):166-169.
114. Sharma D., Flora G., Grunberg S.M. Chemotherapy of metastatic Merkel cell carcinoma: case report and review of the literature. Am J Clin Oncol 1991, 14(2):166-169.
115. Henness S., Vereecken P. Management of Merkel tumours: an evidence-based review. Curr Opin Oncol 2008, 20(3):280-286.
116. Wynne C.J., Kearsley J.H. Merkel cell tumor. A chemosensitive skin cancer. Cancer 1988, 62(1):28-31.
117. Pectasides D., Papaxoinis G., Pectasides E., et al. Merkel cell carcinoma of the skin: a retrospective study of 24 cases by the Hellenic Cooperative Oncology Group. Oncology 2007, 72(3-4):211-218.
118. Voog E., Biron P., Martin J.P., et al. Chemotherapy for patients with locally advanced or metastatic Merkel cell carcinoma. Cancer 1999, 85(12):2589-2595.
119. Tai P.T., Yu E., Winquist E., et al. Chemotherapy in neuroendocrine/Merkel cell carcinoma of the skin: case series and review of 204 cases. J Clin Oncol 2000, 18(12):2493-2499.
120. Poulsen M., Rischin D., Walpole E., et al. Analysis of toxicity of Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group study. Int J Radiat Oncol Biol Phys 2001, 51(1):156-163.
121. Su L.D., Fullen D.R., Lowe L., et al. CD117 (KIT receptor) expression in Merkel cell carcinoma. Am J Dermatopathol 2002, 24(4):289-293.
122. Feinmesser M., Halpern M., Kaganovsky E., et al. c-kit expression in primary and metastatic merkel cell carcinoma. Am J Dermatopathol 2004, 26(6):458-462.
123. Samlowski W.E., Moon J., Tuthill R.J., et al. A phase II trial of imatinib mesylate in merkel cell carcinoma (neuroendocrine carcinoma of the skin): a Southwest Oncology Group study (S0331). Am J Clin Oncol 2010, 33(5):495-499.
124. Swick B.L., Ravdel L., Fitzpatrick J.E., et al. Merkel cell carcinoma: evaluation of KIT (CD117) expression and failure to demonstrate activating mutations in the C-KIT proto-oncogene - implications for treatment with imatinib mesylate. J Cutan Pathol 2007, 34(4):324-329.
125. Kartha R.V., Sundram U.N. Silent mutations in KIT and PDGFRA and coexpression of receptors with SCF and PDGFA in Merkel cell carcinoma: implications for tyrosine kinase-based tumorigenesis. Mod Pathol 2008, 21(2):96-104.
126. Woll P.J., Moore K.N., Bhatia S., et al. Efficacy results from a phase I study of lorvotuzumab mertansine (IMGN901) in patients with CD56-positive solid tumors. J Clin Oncol 2011, 29(Suppl):e.13582. [abstract].
127. Nardi V., Song Y., Santamaria-Barria J.A., et al. Activation of PI3K signaling in Merkel cell carcinoma. Clin Cancer Res 2012, 18(5):1227-1236.
128. Cully M., You H., Levine A.J., et al. Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat Rev Cancer 2006, 6(3):184-192.
129. Kong D., Yaguchi S., Yamori T. Effect of ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor, on DNA-dependent protein kinase. Biol Pharm Bull 2009, 32(2):297-300.
130. Maira S.M., Stauffer F., Brueggen J., et al. Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity. Mol Cancer Ther 2008, 7(7):1851-1863.
131. Hafner C., Houben R., Baeurle A., et al. Activation of the PI3K/AKT pathway in Merkel cell carcinoma. PLoS One 2012, 7(2):e31255.
132. Willmes C., Adam C., Alb M., et al. Type I and II IFNs inhibit merkel cell carcinoma via modulation of the merkel cell polyomavirus T antigens. Cancer Res 2012, 72(8):2120-2128.
133. Krasagakis K., Kruger-Krasagakis S., Tzanakakis G.N., et al. Interferon-alpha inhibits proliferation and induces apoptosis of merkel cell carcinoma in vitro. Cancer Invest 2008, 26(6):562-568.
134. Biver-Dalle C., Nguyen T., Touze A., et al. Use of interferon-alpha in two patients with Merkel cell carcinoma positive for Merkel cell polyomavirus. Acta Oncol 2011, 50(3):479-480.
135. Iyer J.G., Afanasiev O.K., McClurkan C., et al. Merkel cell polyomavirus-specific CD8 and CD4 T-cell responses identified in Merkel cell carcinomas and blood. Clin Cancer Res 2011, 17(21):6671-6680.
136. Zeng Q., Gomez B.P., Viscidi R.P., et al. Development of a DNA vaccine targeting Merkel cell polyomavirus. Vaccine 2012, 30(7):1322-1329.
137. National Institutes of Health. Interleukin-12 gene and in vivo electroporation-mediated plasmid DNA vaccine therapy in treating patients with Merkel cell cancer. Available at: Accessed June 22, 2012. http://clinicaltrials.gov/ct2/show/NCT01440816%3fterm%3dmerkel+cell%26rank%3d3.